Centers for Disease Control and Prevention,National Center for HIV Viral Hepatitis STD and TB Prevention

This report consolidates previous recommendations and adds new ones for preventing and controlling infections with hepatitis viruses among inmates and workers in correctional facilities. The recommendations provide guidelines for juvenile and adult correctional systems regarding (1) identification and investigation of acute viral hepatitis, (2) pre-exposure and postexposure immunization for hepatitis A and B, (3) prevention of hepatitis C virus infection and its consequences, (4) health education, and (5) release planning.

This report focuses on the HIV/AIDS epidemic in the US and the work of the CDC’s division of HIV/AIDS prevention. It provides a brief history of the accomplishments since 1981, discusses the current status of the epidemic in the US and how CDC is responding, using surveillance data reported to CDC from the 25 states with long-standing HIV reporting. It looks back on the successes of HIV/AIDS prevention and presents future plans.

This report is a guide for developing country-specific protocols for conducting evaluations of HIV enzyme immunoassay and rapid/simple test methods in Africa. It includes the background of each test, the importance of rapid/simple assays, the rationale and justification for evaluating new tests, the importance of quality assurance and safety, issues to be considered when planning an evaluation, projected time line for an evaluation, and technical training requirements.

This report provides updated, integrated recommendations for partner services for HIV infection, as well as infection with syphilis, gonorrhea, and chlamydia. These updated recommendations replace the following publications: (1) Program Operations Guidelines for STD Prevention, CDC 2001; and (2) HIV Partner Counseling and Referral Services Guidance, CDC 1998. The updated recommendations serve as a basis for delivery of partner services and related training and technical assistance.

This report presents estimated numbers of cases of HIV/AIDS from the 38 areas (33 states and five US dependent areas) with confidential name-based HIV infection reporting since at least 2003. It also includes the following statistics reported to the CDC through 2006: (1) cases of HIV/AIDS and AIDS; (2) deaths of persons with AIDS; (3) persons living with HIV/AIDS, AIDS, or HIV infection; (4) length of survival after AIDS diagnosis, and (5) reports of cases of HIV/AIDS, AIDS, and HIV infection.

This report presents recommendations for postexposure interventions to prevent hepatitis B virus, hepatitis C virus, or HIV infections and tetanus in persons wounded in bombings or events causing mass casualties. During such events, wounded persons may be exposed to blood, body fluids, or tissue from other injured persons, putting them at risk for bloodborne infections.

This report describes the burden of acute disease attributed to infection with the hepatitis A, hepatitis B, and hepatitis C viruses, and describes acute disease trends in recent years. Cases of acute viral hepatitis are reported weekly by state and territorial health departments to CDC's National Notifiable Diseases Surveillance System. The report includes the methods of collecting data, definitions for acute viral hepatitis, and analyses.

This report presents statistics and trends for sexually transmitted diseases (STDs) in the US through 2007. The information is based on (1) case reports from state and local STD programs; (2) the Regional Infertility Prevention Projects, the National Job Training Program (formerly the Job Corps), the Corrections STD Prevalence Monitoring Project, and the Men Who Have Sex with Men (MSM) Prevalence Monitoring Project; (3) the Gonococcal Isolate Surveillance Project (GISP); and (4) national surveys implemented by federal and private organizations. The report consists of four parts.

This information sheet summarizes national data for 2008 on three STDs: chlamydia, gonorrhea, and syphilis. It presents an overview of key findings about these diseases, including the largest number of reported cases of chlamydia and gonorrhea among adolescent girls and young women; the re-emergence of syphilis, particularly among men who have sex with men (MSM); the relationship between STDs and infertility; and racial disparities among the three reportable STDs.

This information sheet provides evidence concerning the use of the male latex condom to prevent sexually transmitted diseases (STDs), including HIV, gonorrhea, chlamydia, trichomoniasis, genital ulcer diseases, and HPV infections. The evidence is based on information about how different STDs are transmitted, the physical properties of condoms, the anatomic coverage or protection that condoms provide, and epidemiologic studies assessing condom use and STD risk.